5PSQ-067 Detection of adverse neuropsychiatric reactions associated with abiraterone and enzalutamide treatments in the hospital
Published: Mar 1, 2019
Abstract
Background
Enzalutamide (ENZ) and abiraterone acetate (AA) are oral treatments indicated for metastatic castration-resistant prostate cancer (mCPRC). Both drugs can cause neurological and psychiatric adverse effects. Some publications suggest that some neuropsychiatric adverse reactions are more frequent with ENZ than with AA.Purpose
The aim of this study was to check the prevalence of these types of adverse reactions in...Paper Details
Title
5PSQ-067 Detection of adverse neuropsychiatric reactions associated with abiraterone and enzalutamide treatments in the hospital
Published Date
Mar 1, 2019
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History